ardeparin

Low molecular weight heparin (LMWH) is the agent of choice for anticoagulant therapy and prophylaxis of thrombosis and coronary… Expand

L-Arginine is the principal physiological precursor of nitric oxide (NO, a key neurotransmitter) that plays a versatile role in… Expand

RETRACTED 

The antithrombotic drug heparin is administered parenterally and believed not effective orally. Oral heparin would be most… Expand

In addition to its anticoagulant effects, heparin is known to have antiproliferative effects on vascular smooth muscle cells… Expand

There is adequate preclinical data to support the differential biochemical and pharmacological behavior of the currently approved… Expand

BACKGROUND Deep vein thrombosis is common in patients undergoing major knee surgery. Static graduated compression stockings… Expand

Osteoporosis is a well-recognized complication of long-term heparin use. However, the mechanisms by which heparin can influence… Expand

Ardeparin is a low molecular weight heparin currently being evaluated as an antithrombotic agent. The objective of this… Expand

We have compared the non-specific binding of unfractionated heparin (UFH) with that of low molecular weight heparin (LMWH) to… Expand